Collegium Pharmaceutical, Inc.
COLL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,104,684 | $940,640 | $949,043 | $919,052 |
| - Cash | $150,096 | $117,348 | $96,192 | $70,565 |
| + Debt | $813,989 | $829,110 | $844,213 | $859,298 |
| Enterprise Value | $1,768,577 | $1,652,402 | $1,697,064 | $1,707,785 |
| Revenue | $209,361 | $188,000 | $177,757 | $181,949 |
| % Growth | 11.4% | 5.8% | -2.3% | – |
| Gross Profit | $129,171 | $108,384 | $97,324 | $98,288 |
| % Margin | 61.7% | 57.7% | 54.8% | 54% |
| EBITDA | $121,709 | $94,096 | $80,476 | $96,435 |
| % Margin | 58.1% | 50.1% | 45.3% | 53% |
| Net Income | $31,507 | $11,983 | $2,417 | $12,536 |
| % Margin | 15% | 6.4% | 1.4% | 6.9% |
| EPS Diluted | 0.84 | 0.34 | 0.074 | 0.35 |
| % Growth | 147.1% | 362% | -79% | – |
| Operating Cash Flow | $78,438 | $72,439 | $55,398 | $84,644 |
| Capital Expenditures | -$188 | -$65 | -$798 | -$570 |
| Free Cash Flow | $78,250 | $72,374 | $54,600 | $84,074 |